NADAC acquisition cost data for CINACALCET HCL 90 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00591241830 | $4.31 | 2021-12-22 | Rx |
| 00591241830 | $4.31 | 2021-12-22 | Rx |
| 00591241830 | $4.31 | 2021-12-22 | Rx |
| 00591241830 | $4.31 | 2021-12-22 | Rx |
| 00591241830 | $4.31 | 2021-12-22 | Rx |
| 16714008001 | $1.33 | 2022-11-23 | Rx |
| 16729044210 | $1.33 | 2022-11-23 | Rx |
| 16729044215 | $1.33 | 2022-11-23 | Rx |
| 31722010530 | $1.33 | 2022-11-23 | Rx |
| 42543096304 | $1.33 | 2022-11-23 | Rx |
Generic: Cinacalcet HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $91.4M | 95,327 | 26,587 | $25.83 |
| 2020 | $182.4M | 225,738 | 37,269 | $21.32 |
| 2021 | $138.2M | 219,523 | 41,701 | $14.23 |
| 2022 | $120.4M | 229,164 | 46,410 | $11.14 |
| 2023 | $127.8M | 252,530 | 52,976 | $10.06 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.